about
Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats.Roles of Na⁺/H⁺ exchanger type 1 and intracellular pH in angiotensin II-induced reactive oxygen species generation and podocyte apoptosis.Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus.Intrarenal mouse renin-angiotensin system during ANG II-induced hypertension and ACE inhibitionMajor role for ACE-independent intrarenal ANG II formation in type II diabetes.Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats.Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy.Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte.Adipose tissue-specific dysregulation of angiotensinogen by oxidative stress in obesity.Tumor necrosis factor-{alpha} suppresses angiotensinogen expression through formation of a p50/p50 homodimer in human renal proximal tubular cells.Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension.Contribution of renal purinergic receptors to renal vasoconstriction in angiotensin II-induced hypertensive ratsCalcium channel blocker enhances beneficial effects of an angiotensin II AT1 receptor blocker against cerebrovascular-renal injury in type 2 diabetic miceIncreased renin excretion is associated with augmented urinary angiotensin II levels in chronic angiotensin II-infused hypertensive rats.Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease.Short-Term Calorie Restriction in Early Life Attenuates the Development of Proteinuria but Not Glucose Intolerance in Type 2 Diabetic OLETF Rats.Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive ratsThe link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome.The establishment of a primary culture system of proximal tubule segments using specific markers from normal mouse kidneys.Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients.Quantification of human angiotensinogen by a novel sandwich ELISA.Urinary Angiotensinogen Could Be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes.Sexual dimorphism in urinary angiotensinogen excretion during chronic angiotensin II-salt hypertension.Divergent localization of angiotensinogen mRNA and protein in proximal tubule segments of normal rat kidneyThe angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney diseaseActivation of the renin-angiotensin system by a low-salt diet does not augment intratubular angiotensinogen and angiotensin II in ratsCostimulation with angiotensin II and interleukin 6 augments angiotensinogen expression in cultured human renal proximal tubular cells.Angiotensin II blockade and renal protection.Aberrant activation of the intrarenal renin-angiotensin system in the developing kidneys of type 2 diabetic rats.Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet.Collecting duct renin is upregulated in both kidneys of 2-kidney, 1-clip goldblatt hypertensive rats.Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISAUrinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patientsThe growth factor midkine regulates the renin-angiotensin system in miceIL-6 augments angiotensinogen in primary cultured renal proximal tubular cells.Contribution of chymase-dependent angiotensin II formation to the progression of tubulointerstitial fibrosis in obstructed kidneys in hamsters.Oxidative stress/angiotensinogen/renin-angiotensin system axis in patients with diabetic nephropathyNew Generation Calcium Channel Blockers in Hypertensive Treatment.Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetesRenoprotective effects of direct renin inhibition in glomerulonephritis.
P50
Q30492950-5F550DC4-0AF6-4B3D-A939-A7087DB78777Q31122004-45865EEE-7571-415F-8F0B-6261521B84B9Q33585798-13AFEDD4-EF05-47A4-9BD1-B846AD0B875AQ33589076-AF571C05-6669-4092-A7E1-B0CD14B46419Q33589120-DD2FE269-32F0-4CA6-83A9-51A962340ACEQ33714897-0A188B18-6E4A-485B-9613-434025FD392FQ33742195-34243E51-FD6F-4596-9F42-C7951C7A8D7AQ33887622-3EFAA724-0F6B-4C7D-9F05-6C1C5645F74DQ33936984-0CA35456-9E3D-4839-BB97-8924F378F76CQ34211709-92FFCB6C-548F-4BFA-A79D-91B600CB81C3Q34785905-A79A8C66-F310-443E-B903-17B217B9C783Q35057133-47B1566B-EF02-42DB-8CD3-9502FE4573A9Q35067693-BE2310B3-E27E-4F5C-92A6-D7B453BA7C5DQ35601621-4A4A2BA3-A0FF-4F28-AB15-4D0A8FB8F889Q35663915-2C682114-FD5B-4087-BCE0-0BFA2133A765Q35684699-B579BD66-0967-4DF5-BD85-175552967861Q35791464-DBED9388-4345-40D3-B9CB-39467ABFF062Q35916243-D52B0B16-534B-4A3B-92D0-78EA5697BA8AQ35934092-F6B61EE9-AEDE-459A-975B-576F36DFA4F0Q35995685-93E56783-462E-406D-B646-B6BED27F0C9AQ36015333-7236889C-E3FB-4EEE-B103-CE5C08F3ED13Q36035037-0C19D368-0071-474E-893D-B042BF3DF786Q36166426-4E3F7C5D-92EF-4302-9300-EBD8649CA587Q36405827-35887517-8017-4130-8415-33621DEF86FCQ36675029-C2BE8CB5-ED9E-4635-AB59-BDBBE2A3C1EDQ36699872-947EE5AB-BCF7-4B70-9267-81120F915BF2Q36807104-BFEFF3AE-6789-4AFB-AAC6-6D02692FDE69Q36836004-4F6F624D-051A-45A1-9834-D5AAC926462FQ36847492-DFA90280-87F5-45EE-B4C7-B29D4D2774FEQ36948052-163B2F55-9BD8-471A-9801-7307F0BB167CQ37013019-B28A8DEA-02A5-4540-A4C0-182DCEF74A00Q37029541-D135F527-0AD6-46C4-8856-DD23FD37E8EDQ37135790-8495270A-A693-46BF-9F61-CA8C564223D9Q37209205-B0166355-9FEF-4AFE-B934-49C85FEAB305Q37336175-B2A0026D-68B7-49D2-94BE-0F8E3CF9D43EQ37367978-177E9FF8-6572-4DC0-A68B-138FCA997792Q37375567-3E43AF14-E9DC-4A0C-97A9-9F421C2DC09AQ37381991-09FCE042-593F-4068-A4F4-888042557EFBQ37483178-33BF1F3B-FA4A-4BFF-A6D0-A2D70695BBB9Q37724291-2B4A6AA6-7B6E-4FF1-AA88-DD62D14F0CC2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Hiroyuki Kobori
@ast
Hiroyuki Kobori
@en
Hiroyuki Kobori
@es
Hiroyuki Kobori
@nl
Hiroyuki Kobori
@sl
type
label
Hiroyuki Kobori
@ast
Hiroyuki Kobori
@en
Hiroyuki Kobori
@es
Hiroyuki Kobori
@nl
Hiroyuki Kobori
@sl
prefLabel
Hiroyuki Kobori
@ast
Hiroyuki Kobori
@en
Hiroyuki Kobori
@es
Hiroyuki Kobori
@nl
Hiroyuki Kobori
@sl
P1053
F-1994-2014
P106
P1153
26643284900
P21
P31
P3829
P496
0000-0001-5128-5059
P569
2000-01-01T00:00:00Z